In addition, five of 45 IDH1-R132H-negative gliomas were oligodendrogliomas, which carried non-canonical IDH1/2 mutations (1 IDH1-R132L, 4 IDH2-R172 Mut). Here, IDH2 is linked to central nervous system cancer.